Common use of Reporting to Other Party Clause in Contracts

Reporting to Other Party. Each Party shall, and shall cause its respective Affiliates to, furnish the other Party written notice of all Serious Adverse Events regarding any Licensed Product reported to such Party or its Affiliates. Each Party shall also use its [ * ] to obtain, and to furnish to the other Party hereto, such information reasonably sufficient to permit that other Party to evaluate such Serious Adverse Events of the Licensed Product, including, but not limited to, information about the affected patients, the circumstances surrounding the Serious Adverse Events, the consequences thereof and the sources of information. Each Party shall retain all documents, reports, studies and other materials relating to any and all such Serious Adverse Events, as the case may be. Upon reasonable written notice, each Party shall permit the other Party hereto to inspect, and to make copies of, all such documents, reports, studies and other materials, subject to all Applicable Laws regarding patient confidentiality, data protection and privacy.

Appears in 2 contracts

Samples: License and Collaboration Agreement (Seattle Genetics Inc /Wa), License and Collaboration Agreement (Seattle Genetics Inc /Wa)

AutoNDA by SimpleDocs

Reporting to Other Party. Each Party shall, and shall cause its respective Affiliates to, furnish the other Party written notice of all Serious Adverse Events regarding any Licensed Collaboration Product reported to such Party or its Affiliates. Each Party shall also use its [ * ] Commercially Reasonable Efforts to obtain, and to furnish to the other Party hereto, such information reasonably sufficient to permit that other Party to evaluate such Serious Adverse Events of the Licensed Collaboration Product, including, but not limited to, information about the affected patients, the circumstances surrounding the Serious Adverse Events, the consequences thereof and the sources of information. Each Party shall retain all documents, reports, studies and other materials relating to any and all such Serious Adverse Events, as the case may be. Upon reasonable written notice, each Party shall permit the other Party hereto to inspect, and to make copies of, all such documents, reports, studies and other materials, subject to all Applicable Laws regarding patient confidentiality, data protection and privacy. The Parties agree that with regards to the Unilateral Products, the obligations set forth in this Section 5.5b shall only apply to the Continuing Party.

Appears in 2 contracts

Samples: License and Collaboration Agreement (Agreement (BioNTech SE), License and Collaboration Agreement (Agreement (BioNTech SE)

Reporting to Other Party. Each Party shall, and shall cause its respective Affiliates to, furnish the other Party written notice of all Serious Adverse Events regarding any Licensed Product reported to such Party or its Affiliates. Each Party shall also use its [ * [***] to obtain, and to furnish to the other Party hereto, such information reasonably sufficient to permit that other Party to evaluate such Serious Adverse Events of the Licensed Product, including, but not limited to, information about the affected patients, the circumstances surrounding the Serious Adverse Events, the consequences thereof and the sources of information. Each Party shall retain all documents, reports, studies and other materials relating to any and all such Serious Adverse Events, as the case may be. Upon reasonable written notice, each Party shall permit the other Party hereto to inspect, and to make copies of, all such documents, reports, studies and other materials, subject to all Applicable Laws regarding patient confidentiality, data protection and privacy.

Appears in 2 contracts

Samples: License and Collaboration Agreement (Genmab a/S), License and Collaboration Agreement (Genmab a/S)

Reporting to Other Party. Each Party shall, and shall cause its respective Affiliates to, furnish the other Party written notice of all Serious Adverse Events regarding any Licensed LCA Product reported to such Party or its Affiliates. Each Party shall also use its [ * ] Commercially Reasonable Efforts to obtain, and to furnish to the other Party hereto, such information reasonably sufficient information relating to such Serious Adverse Event in order to permit that other Party to evaluate such Serious Adverse Events of the Licensed LCA Product, including, but not limited to, information about the affected patients, the circumstances surrounding the Serious Adverse Events, the consequences thereof and the sources of information. Each Party shall retain all documents, reports, studies and other materials relating to any and all such Serious Adverse Events, as the case may be. Upon reasonable written notice, each Party shall permit the other Party hereto to inspect, and to make copies of, all such documents, reports, studies and other materials, subject to all Applicable Laws regarding patient confidentiality, data protection and privacyprivacy and the terms of the Data Protection Agreement. The Parties agree that with regards to the Unilateral Products, the obligations set forth in this Section 7.5(b) shall only apply to the Continuing Party.

Appears in 1 contract

Samples: License and Collaboration Agreement (BioNTech SE)

AutoNDA by SimpleDocs

Reporting to Other Party. Each Party shall, and shall cause its respective Affiliates to, furnish the other Party written notice of all side effects, drug interactions and other Serious Adverse Events regarding any Licensed a Product reported to such Party or its AffiliatesAffiliates within [***] after any such report. Each Party shall also use its [ * ] best efforts to obtain, and to furnish to the [***] Certain information on this page has been omitted and filed separately with the Securities and Exchange Commission. Confidential treatment has been requested with respect to the omitted portions. other Party hereto, such information information, including, but not limited to, patients, circumstances, consequences and sources of information, reasonably sufficient to permit that other Party to evaluate such side effects, drug interactions or other Serious Adverse Events of the Licensed Product, including, but not limited to, information about the affected patients, the circumstances surrounding the Serious Adverse Events, the consequences thereof and the sources of information. Each Party shall retain all documents, reports, studies and other materials relating to any and all such side effects, drug interactions, or other Serious Adverse Events, as the case may be. Upon reasonable written notice, each Party shall permit the other Party hereto to inspect, and to make copies of, all such documents, reports, studies and other materials, subject to all Applicable Laws applicable laws and regulations regarding patient confidentiality, data protection confidentiality and privacy.

Appears in 1 contract

Samples: Collaboration and License Agreement (Seattle Genetics Inc /Wa)

Time is Money Join Law Insider Premium to draft better contracts faster.